Rhythm Pharmaceuticals, Inc.
RYTM • NASDAQ
Rhythm Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Meeker, with a market cap of $6.4B.
CEODavid Meeker
Next Earnings
Upcoming earnings announcement for Rhythm Pharmaceuticals, Inc.
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.83
Revenue Estimate
$56.6M
Earnings History
Past 12 earnings reports for Rhythm Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | Q4 2025 | -$0.73Est: -$0.78 | +6.4% | $57.3MEst: $55.8M | +2.5% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.82Est: -$0.72 | -13.9% | $51.3MEst: $50.5M | +1.6% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.75Est: -$0.67 | -11.9% | $48.5MEst: $43.5M | +11.4% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.81Est: -$0.68 | -19.1% | $32.7MEst: $40.7M | -19.6% | 10-Q |
| Feb 26, 2025 | Q4 2024 | -$0.72Est: -$0.73 | +1.4% | $41.8MEst: $38.5M | +8.7% | 10-K |
| Nov 5, 2024 | Q3 2024 | -$0.73Est: -$0.80 | +8.8% | $33.3MEst: $32.5M | +2.2% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.55Est: -$0.71 | +22.5% | $29.1MEst: $29.3M | -0.7% | 10-Q/A |
| May 7, 2024 | Q1 2024 | -$2.35Est: -$2.16 | -8.8% | $26.0MEst: $26.9M | -3.5% | 10-Q |
| Feb 22, 2024 | Q4 2023 | -$0.70Est: -$0.70 | 0.0% | $24.2MEst: $25.4M | -4.5% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.76Est: -$0.76 | 0.0% | $22.5MEst: $22.2M | +1.5% | — |
| Aug 1, 2023 | Q2 2023 | -$0.82Est: -$0.81 | -1.2% | $19.2MEst: $14.8M | +30.0% | — |
| May 2, 2023 | Q1 2023 | -$0.92Est: -$0.73 | -26.0% | $11.5MEst: $12.1M | -5.4% | — |